IBDEI0ZM ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15890,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,15890,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,15890,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,15891,0)
 ;;=L60.1^^88^869^272
 ;;^UTILITY(U,$J,358.3,15891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15891,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,15891,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,15891,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,15892,0)
 ;;=L60.2^^88^869^271
 ;;^UTILITY(U,$J,358.3,15892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15892,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,15892,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,15892,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,15893,0)
 ;;=L60.3^^88^869^176
 ;;^UTILITY(U,$J,358.3,15893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15893,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,15893,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,15893,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,15894,0)
 ;;=L60.4^^88^869^89
 ;;^UTILITY(U,$J,358.3,15894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15894,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,15894,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,15894,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,15895,0)
 ;;=L60.5^^88^869^330
 ;;^UTILITY(U,$J,358.3,15895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15895,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,15895,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,15895,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,15896,0)
 ;;=L60.8^^88^869^174
 ;;^UTILITY(U,$J,358.3,15896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15896,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,15896,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,15896,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,15897,0)
 ;;=L62.^^88^869^175
 ;;^UTILITY(U,$J,358.3,15897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15897,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,15897,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,15897,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,15898,0)
 ;;=L64.9^^88^869^34
 ;;^UTILITY(U,$J,358.3,15898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15898,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,15898,1,4,0)
 ;;=4^L64.9
 ;;^UTILITY(U,$J,358.3,15898,2)
 ;;=^5009249
 ;;^UTILITY(U,$J,358.3,15899,0)
 ;;=L65.9^^88^869^269
 ;;^UTILITY(U,$J,358.3,15899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15899,1,3,0)
 ;;=3^Nonscarring Hair Loss,Unspec
 ;;^UTILITY(U,$J,358.3,15899,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,15899,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,15900,0)
 ;;=L70.0^^88^869^7
 ;;^UTILITY(U,$J,358.3,15900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15900,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,15900,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,15900,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,15901,0)
 ;;=L70.1^^88^869^2
 ;;^UTILITY(U,$J,358.3,15901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15901,1,3,0)
 ;;=3^Acne Conglobata
 ;;^UTILITY(U,$J,358.3,15901,1,4,0)
 ;;=4^L70.1
 ;;^UTILITY(U,$J,358.3,15901,2)
 ;;=^5009269
 ;;^UTILITY(U,$J,358.3,15902,0)
 ;;=L70.3^^88^869^6
 ;;^UTILITY(U,$J,358.3,15902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15902,1,3,0)
 ;;=3^Acne Tropica
 ;;^UTILITY(U,$J,358.3,15902,1,4,0)
 ;;=4^L70.3
 ;;^UTILITY(U,$J,358.3,15902,2)
 ;;=^5009270
 ;;^UTILITY(U,$J,358.3,15903,0)
 ;;=L70.5^^88^869^3
 ;;^UTILITY(U,$J,358.3,15903,1,0)
 ;;=^358.31IA^4^2
